Michal Kunz
About
In The Last Decade
Michal Kunz
17 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 80
- Psychiatry and Mental health 740
- Cognitive Neuroscience 306
- Clinical Psychology 301
- Cellular and Molecular Neuroscience 165
- Philosophy 115
Countries citing papers authored by Michal Kunz
This map shows the geographic impact of Michal Kunz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Kunz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Kunz more than expected).
Fields of papers citing papers by Michal Kunz
This network shows the impact of papers produced by Michal Kunz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Kunz. The network helps show where Michal Kunz may publish in the future.
Co-authorship network of co-authors of Michal Kunz
This figure shows the co-authorship network connecting the top 25 collaborators of Michal Kunz. A scholar is included among the top collaborators of Michal Kunz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Kunz. Michal Kunz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 19 | |
| 4 | 24 | |
| 5 | Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial | 1 |
| 6 | A cognitive, behaviorally based program for patients with persistent mental illness and a history of aggression, crime, or both: structure and correlates of completers of the program. | 6 |
| 7 | 37 | |
| 8 | 66 | |
| 9 | 15 | |
| 10 | 278 | |
| 11 | 436 | |
| 12 | 16 | |
| 13 | 30 | |
| 14 | 23 | |
| 15 | 10 | |
| 16 | Open-label trial of venlafaxine in adults with attention deficit disorder. | 59 |
| 17 | 41 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.